SAMHD1 p.Arg3Leu
c.8G>T · rs551472065 · VCV835265
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0882 | likely benign |
|---|---|---|
| REVEL | 0.221 | benign-leaning |
| SaProt | LLR -6.83 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -1.6 | GERP -3.2 |
| Regional constraint | o/e 0.85 | unconstrained · MANE · 59 kb · p 1.9e-05 · regional, not allelic |
| Overall | ||
| CADD | 7.398 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Admixed Americangrpmax | 0.01% | 10,004 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,444 |
| African / African-American | 0.00133% | 75,042 |
| European (non-Finnish) | 0.000339% | 294,997 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- SAMHD1
- Protein
- p.Arg3Leu
- Coding
- c.8G>T
- MANE Select
- NM_015474
- dbSNP
- rs551472065
- Type
- single nucleotide variant
- Location
- chr20:36951636 (GRCh38)
- Gene constraint
- LOEUF 0.889 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 88.45 · 76 PDB
- Residue 3
- the 'disordered' region
Disease context
Aicardi-Goutieres syndrome 5 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: Aicardi-Goutieres syndrome
For Aicardi-Goutières syndrome (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive
- Onset
- Antenatal, Infancy, Neonatal
- Prevalence
- 1-5 / 10 000 (Europe)
Similar variants
- SAMHD1 p.Arg3= Likely benign ★ same residue
- SAMHD1 c.1062+1G>T Pathogenic/Likely pathogenic ★★ same condition
- SAMHD1 c.1411-2A>G Pathogenic ★★ same condition
- SAMHD1 c.509+1G>A Likely pathogenic ★★ same condition
- SAMHD1 c.626-1G>C Pathogenic/Likely pathogenic ★★ same condition
- SAMHD1 p.Arg106Ter Pathogenic/Likely pathogenic ★★ same condition
- SAMHD1 p.Arg134Ter Pathogenic/Likely pathogenic ★★ same condition
- SAMHD1 p.Arg143Cys Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/samhd1-p-arg3leu (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown